Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Efficacy of a therapeutic cocaine vaccine in rodent models

Abstract

Cocaine abuse is a major medical and public health concern in the United States, with approximately 2.1 million people dependent on cocaine1. Pharmacological approaches to the treatment of cocaine addiction have thus far been disappointing2,3, and new therapies are urgently needed. This paper describes an immunological approach to cocaine addiction. Antibody therapy for neutralization of abused drugs has been described previously4, including a recent paper demonstrating the induction of anti–cocaine antibodies5. However, both the rapidity of entry of cocaine into the brain6 and the high doses of cocaine frequently encountered7 have created challenges for an antibody–based therapy. Here we demonstrate that antibodies are efficacious in an animal model of addiction. Intravenous cocaine self–administration in rats was inhibited by passive transfer of an anti–cocaine monoclonal antibody. To actively induce anti–cocaine antibodies, a cocaine vaccine was developed that generated a high–titer, long–lasting antibody response in mice. Immunized mice displayed a significant change in cocaine pharmacokinetics, with decreased levels of cocaine measured in the brain of immunized mice only 30 seconds after intravenous (i.v.) administration of cocaine. These data establish the feasibility of a therapeutic cocaine vaccine for the treatment of cocaine addiction.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Institute of Medicine. Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector. (National Academy Press, Washington, DC, 1995).

  2. Carroll, F.I., Lewin, A.H. & Biswas, J. Chemical approaches to the treatment of cocaine abuse. Pharm. News 1, 11–16 (1994).

    CAS  Google Scholar 

  3. Bonese, K.F., Wainer, B.H., Fitch, F.W., Rothberg, R.M. & Schuster, C.R. Changes in heroin self-administration by a rhesus monkey after morphine immunization. Nature 252, 708–710 (1974).

    Article  CAS  Google Scholar 

  4. Carrera, M.R.A., Ashley, J.A., Parsons, L.H., Wirsching, P., Koob, G.F. & Janda, K.D. Suppression of psychoactive effects of cocaine by active immunization. Nature 378, 727–730 (1995).

    Article  CAS  Google Scholar 

  5. Nutt, D.J. Addiction: Brain mechanisms and their treatment implications. Lancet 347, 31–36 (1996).

    Article  CAS  Google Scholar 

  6. Johanson, C.-E. & Fischman, M.W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41, 3–52 (1989).

    CAS  PubMed  Google Scholar 

  7. Katz, J. & Goldberg, S.R. Second-order schedules of drug injection. in Methods of Assessing the Reinforcing Properties of Abused Drugs. (ed. Bosarth, M.) 105–111 (Springer, New York, 1987).

    Chapter  Google Scholar 

  8. Bergman, J., Kamien, J.B. & Spealman, R.D. Antagonism of cocaine self-administration by selective dopamine Dl D2 antagonists. Behav. Pharmacol. 1, 355–363 (1990).

    Article  Google Scholar 

  9. Woods, J.H., Winger, G.D. & France, C.P. Reinforcing and discriminative stimulus effects of cocaine: Analysis of pharmacological mechanisms. in Cocaine: Clinical and Biobehavioral Aspects. (eds. Fisher, S., Raskin, A. & Uhlenhuth, E.) 21–65 (Oxford Univ. Press, New York, 1987).

    Google Scholar 

  10. Goldberg, S.R., Spealman, R.D., Risner, M.F. & Henningfield, J.E. Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol. Biochem. Behav. 19, 1011–1020 (1983).

    Article  CAS  Google Scholar 

  11. Bodanszky, M. The myth of coupling reagents. Peptide Res. 5, 134–139 (1992).

    CAS  Google Scholar 

  12. Jindal, S.P. & Lutz, T. Mass spectrometric studies of cocaine disposition in animals and humans using stable isotope-labeled analogues. J. Pharm. Sci. 78, 1009–1014 (1989).

    Article  CAS  Google Scholar 

  13. Jeffcoat, A.R., Perez-Reyes, M., Hill, J.M., Sadler, B.M. & Cook, C.E. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab. Disposition 17, 153–159 (1989).

    CAS  Google Scholar 

  14. Jatlow, P. et al. Cocaethylene: A neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 48, 1787–1794 (1991).

    Article  CAS  Google Scholar 

  15. Steward, M.W. Overview: Introduction to methods used to study the affinity and kinetics of antibody-antigen reactions. in Handbook of Experimental Immunology, Vol. 1, Immunochemistry. (ed. Weir, D.M.) 25.1–25.30 (Blackwell Scientific, Oxford, 1986).

    Google Scholar 

  16. Jatlow, P.J. Cocaine: Analysis, pharmacokinetics, and metabolic disposition. Yale J. Biol. Med. 61, 105–113 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Benowitz, N.L. Clinical pharmacology and toxicology of cocaine. Pharmacol. Toxicol. 72, 3–12 (1993).

    Article  CAS  Google Scholar 

  18. Oldendorf, W.H. Some relationships between addiction and drug delivery to the brain. in Bioavailability of Drugs to the Brain and the Blood-Brain Barrier. (eds. Frankenheim, J. & Brown, R.M.) NIDA Res. Monogr. 120, 13–25 (1992).

    Google Scholar 

  19. Kirchner, J.G. Thin-layer chromatography. Tech. Chem. 14, 736–737 (1978).

    Google Scholar 

  20. Kantak, K.M., Wasserman, S.J., Lawley, S.I. & O'Connor, T. Acute and multiple injection effects of magnesium on responding maintained by cocaine, extinction from cocaine, glucose + saccharin, and food. Pharmacol. Biochem. Behav. 41, 415–423 (1992).

    Article  CAS  Google Scholar 

  21. Rothstein, T.L. & Gefter, M.L. Affinity analysis of idiotype-positive and idiotype-negative Ars-binding hybridoma proteins and Ars-immune serum. Mol. Immunol. 20, 161–168 (1983).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, B., Kantak, K., Edwards, M. et al. Efficacy of a therapeutic cocaine vaccine in rodent models. Nat Med 2, 1129–1132 (1996). https://doi.org/10.1038/nm1096-1129

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1096-1129

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing